Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa

BMC Infectious Diseases

Anne von Gottberg⁶  Shabir A. Madhi⁴  Michelle J. Groome⁴  Marietjie Venter⁷  Florette Treurnicht³  Susan Nzenze²  Linda de Gouveia³  Jocelyn Moyes⁵  Adam L. Cohen¹  Claire von Mollendorf⁵  Sibongile Walaza⁵  Cheryl Cohen⁵  Nicole Wolter⁶  Stefano Tempia³ 

[1] Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA;Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa;Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa;Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa;School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;Division of Global Health Protection, Centers for Disease Control and Prevention, Pretoria, South Africa

关键词: South Africa;    Molecular serotyping;    lytA;    Conjugate vaccine;    Pneumococcus;   

Others  :  1232849
DOI  :  10.1186/s12879-015-1198-z

 received in 2015-06-17, accepted in 2015-10-08,  发布年份 2015

【 摘 要 】

Background

The use of molecular diagnostic techniques for the evaluation of the impact of pneumococcal conjugate vaccines (PCVs) has not been documented. We aimed to evaluate the impact of PCVs on invasive pneumococcal disease (IPD) using polymerase chain reaction (PCR)-based techniques and compare with results obtained from culture-based methods.

Methods

We implemented two independent surveillance programs for IPD among individuals hospitalized at one large surveillance site in Soweto, South Africa during 2009–2012: (i) PCR-based (targeting the lytA gene) syndromic pneumonia surveillance; and (ii) culture-based laboratory surveillance. Positive samples were serotyped. The molecular serotyping assay included targets for 42 serotypes including all serotypes/serogroups included in the 7-valent (PCV-7) and 13-valent (PCV-13) PCV. The Quellung reaction was used for serotyping of culture-positive cases. We calculated the change in rates of IPD (lytA- or culture-positive) among HIV-uninfected children aged <2 years from the year of PCV-7 introduction (2009) to the post-vaccine years (2011 or 2012).

Results

During the study period there were 607 lytA-positive and 1,197 culture-positive cases that were serotyped. Samples with lytA cycle threshold (Ct)-values ≥35 (30.2 %; 123/407) were significantly less likely to have a serotype/serogroup detected for serotypes included in the molecular serotyping assay than those with Ct-values <35 (78.0 %; 156/200) (p < 0.001). From 2009 to 2012 rates of PCV-7 serotypes/serogroups decreased −63.8 % (95 % CI: −79.3 % to −39.1 %) among lytA-positive cases and −91.7 % (95 % CI: −98.8 % to −73.6 %) among culture-positive cases. Rates of lytA-positive non-vaccine serotypes/serogroups also significantly decreased (−71.7 %; 95 % CI: −81.1 % to −58.5 %) over the same period. Such decline was not observed among the culture-positive non-vaccine serotypes (1.2 %; 95 % CI: −96.7 % to 58.4 %).

Conclusions

Significant downward trends in IPD PCV-7 serotype-associated rates were observed among patients tested by PCR or culture methods; however trends of non-vaccine serotypes/serogroups differed between the two groups. Misclassifications of serotypes/serogroups, affecting the use of non-vaccine serotypes as a control group, may have occurred due to the low performance of the serotyping assay among lytA-positive cases with high Ct-values. Until PCR methods improve further, culture methods should continue to be used to monitor the effects of PCV vaccination programs on IPD incidence.

【 授权许可】

   
2015 Tempia et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M et al.. Global, regional, and national age-sex specific all-cause and cause specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015; 385(9963):117-71.
• [2]Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, et al. Biochemical, genetic, and serological characterization of two capsule subtypes of Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem. 2012;287(33):27885–94.
• [3]Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R et al.. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010; 7:10.
• [4]von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C et al.. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014; 371(20):1889-99.
• [5]Austrian R. The Quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976; 43(6):699-709.
• [6]Progress in introduction of pneumococcal conjugate vaccine – worldwide, 2000–2012. MMWR Morb Mort Wkly Rep. 2013; 62(16):308-311.
• [7]Frean J, Perovic O, Fensham V, McCarthy K, von Gottberg A, de Gouveia L et al.. External quality assessment of national public health laboratories in Africa, 2002–2009. Bull World Health Organ. 2012; 90(3):191-199A.
• [8]Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, Schremmer RD et al.. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. 2008; 122(4):726-30.
• [9]Resti M, Micheli A, Moriondo M, Becciolini L, Cortimiglia M, Canessa C et al.. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther. 2009; 31(6):1266-73.
• [10]Azzari C, Moriondo M, Indolfi G, Massai C, Becciolini L, de Martino M, et al. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol. 2008;57(Pt 10):1205–12.
• [11]Benson R, Tondella ML, Bhatnagar J, Carvalho Mda G, Sampson JS, Talkington DF, et al. Development andevaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens. J Clin Microbiol. 2008;46(6):2074-7.
• [12]Carvalhanas TR, Ribeiro AF, Kemp B, Salgado MM, Shutt KA, Carvalhanas TR et al.. Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in Sao Paulo. Brazil. PLoS One. 2011; 6(6): Article ID e20675
• [13]Statistics South Africa. Population statistics. http://www.statssa.gov.za/?page_id=1854&PPN=P0302. Accessed 15 January 2015.
• [14]Cohen C, Moyes J, Tempia S, Groom M, Walaza S, Pretorius M, et al. Severe influenza-associated lower respiratory tract infection in a high HIV-Prevalence setting – South Africa, 2009–2011. Emerg Infec Dis. 2013;19(11):1766–74.
• [15]Moyes J, Cohen C, Pretorius M, Groome M, von Gottberg A, Wolter N et al.. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011. J Infect Dis. 2013; 208(S3):S217-26.
• [16]Carvalho M, Tondella ML, McCaustland K, Groome M, von Gottberg A, Wolter N, et al. Evaluation of improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45(8):2460–6.
• [17]Azzari C, Moriondo M, Indolfi G, Cortimiglia M, Canessa C, Becciolini L et al.. Real-time PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One. 2010; 5(2): Article ID e9282
• [18]Wolter N, Cohen C, Tempia S, Madhi SA, Venter M, Moyes J et al.. HIV and influenza virus infection are associated with increased blood pneumococcal load: a prospective hospital-based observational study in South Africa, 2009–2011. J Infcet Dis. 2014; 209(1):56-65.
• [19]Magomani V, Wolter N, Tempia S, du Plessis M, de Gouveia L, von Gottberg A et al.. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol. 2014; 52(9):3271-6.
• [20]Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM et al.. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010; 201(1):32-41.
• [21]Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011; 11(10):760-8.
• [22]Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States 1998–2003. MMWR Morb Mortal Wkly Rep. 2005; 54(36):893-897.
• [23]Cohen AL, Harrison LH, Farley MM, Reingold AL, Hadler J, Schaffner W et al.. Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS. 2010; 24(14):2253-62.
• [24]Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ. 2012; 90(8):568-77.
• [25]von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A et al.. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003–2008. Vaccine. 2013; 31(38):4200-8.